Global Nuclear Medicine Imaging Equipment Industry

Sep 16, 2014, 21:10 ET from Reportlinker

NEW YORK, Sept. 16, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Million by the following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and PET Scanners (Includes PET and PET/CT systems). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 31 companies including many key and niche players such as -

Digirad Corp.
GE Healthcare Plc
Mediso Medical Imaging Systems
Philips Healthcare
Positron Corporation

Read the full report: http://www.reportlinker.com/p02365016-summary/view-report.html

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Single-Photon Emission Computed Tomography (SPECT) Systems I-3
SPECT/CT Systems I-4
PET Scanners I-4
PET/CT Systems I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW AND OUTLOOK II-1
Nuclear Medicine Imaging Equipment - A Prelude II-1
Impact of Recession on the Nuclear Medicine Market: In Retrospect II-2
The Road to Recovery II-2
Impact of Healthcare Budget Cuts in Developed Economies: A Review II-2
Positive Outlook for the Healthcare Industry Signals Growth II-3
Table 1: Healthcare Spending as a Percentage of GDP in Select
Developed Countries (includes corresponding Graph/Chart) II-4
US - The Dominant Market II-5
Table 2: US Cancer Incidence by Gender: 2014E (includes
corresponding Graph/Chart) II-5
Developing Nations Offer Lucrative Opportunities II-5
Table 3: Healthcare Spending as a Percentage of GDP in Select
Developing Countries - Lower Share Promising Potential: 2012
(includes corresponding Graph/Chart) II-6
Personalized Medicine Slowly Gaining Ground II-6
Table 4: Drug Ineffectiveness for Select Therapeutic
Categories as a Percentage of Patient Population (includes
corresponding Graph/Chart) II-6
Rising Incidence of Cancer - A Major Growth Driver II-8
World Cancer Statistics - Incidence and Mortality Data II-8
Table 5: World Cancer Incidence by Geographic Region (2012):
Number of New Cancer Cases Reported in Thousands for
Asia-Oceania, Europe, North America, Latin America & the
Caribbean, and Africa (includes corresponding Graph/Chart) II-8

Table 6: World Cancer Mortality by Geographic Region and
Gender (2012): Number of Cancer-Related Deaths in Thousands
for Asia-Oceania, Europe, North America, Latin America & the
Caribbean, and Africa (includes corresponding Graph/Chart) II-9

Table 7: Global Incidence of Common Cancers in Men (2012):
Number of New Cases Reported in Thousands for Lung &
Bronchus, Prostate, Colorectal and Liver Cancers (includes
corresponding Graph/Chart) II-9

Table 8: Global Incidence of Common Cancers in Women (2012):
Number of New Cases Reported in Thousands for Breast,
Colorectal, Lung & Bronchus and Liver Cancers (includes
corresponding Graph/Chart) II-10

Table 9: Global Cancer Mortality in Men for Select Cancers
(2012): Number of Deaths in Thousands for Lung & Bronchus,
Liver, Colorectal and Prostate Cancers (includes
corresponding Graph/Chart) II-10

Table 10: Global Cancer Mortality in Women for Select
Cancers (2012): Number of Deaths in Thousands for Breast,
Lung & Bronchus, Colorectal and Liver (includes
corresponding Graph/Chart) II-10

Table 11: World Breast Cancer Statistics: Top 20 Countries
with Highest Breast Cancer Rates (includes corresponding
Graph/Chart) II-11
Cancer Prone Sites based on Age II-11
Table 12: Cancer Incidence in Developed Nations By Site:
2012 (includes corresponding Graph/Chart) II-12
Software Developments Improve Nuclear Medicine Imaging II-12
Competitive Landscape II-13
Competitive Overview in Nuclear Medicine Market II-13
Table 13: Global SPECT Systems (Gamma Cameras) Market by
Leading Player (2013): Percentage Market Share Breakdown of
Value Sales for GE, Philips, Siemens, and Others (includes
corresponding Graph/Chart) II-13

Table 14: Global PET Scanner Market by Leading Player
(2013): Percentage Market Share Breakdown of Value Sales for
GE, Philips, Siemens, and Others (includes corresponding
Graph/Chart) II-13
A Completive Analysis of Major Players in the Nuclear
Medicine Market II-14

2. MARKET TRENDS AND ISSUES II-15
Hybrid Imaging to Herald a New Era of Diagnosis II-15
Duration of Hybrid Imaging Procedure Bodes Well for Market II-15
Major Players Come Up with New Hybrid PET/MRI Systems II-16
Broad Clinical Applications to Drive Demand for Hybrid PET/MR
Systems II-16
Digital Silicon Photomultiplier Array for PET/MRI Systems II-17
PET-MRI Emerging as a Promising Standard for Imaging Soft
Tissue Contrast II-17
Technology Innovations Promise Bright Prospects II-17
Technological Advancements to Drive Growth II-18
Advances in Software II-18
Iterative Reconstruction II-18
Resolution Recovery II-18
Noise Compensation II-19
Hardware Developments II-19
Solid-State Detectors II-19
Innovative Radiopharmaceuticals to Boost Cardiac Applications II-19
Global CVD Stats II-20
Table 15: Global Estimated Fatalities by Heart Conditions -
Percentage Share Breakdown for Ischemic Heart Disease,
Stroke, CVD, and Others (includes corresponding Graph/Chart) II-20

Table 16: Projected Fatalities in Low Income Countries by
Disease (2015 & 2030): Percentage Share Breakdown of Number
of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;
Malnutrition; and Others (includes corresponding
Graph/Chart) II-21

Table 17: Projected Fatalities in Mid Income Countries by
Disease (2015 & 2030): Percentage Share Breakdown of Number
of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;
Malnutrition; and Others (includes corresponding
Graph/Chart) II-21

Table 18: Projected Fatalities in High Income Countries by
Disease (2015 & 2030): Percentage Share Breakdown of Number
of Deaths for CVD, Cancer, Injury and Others (includes
corresponding Graph/Chart) II-22

Table 19: Estimated Annual Medical Cost (US$ Billions) for
Coronary Heart Disease (2015, 2020 & 2025) (includes
corresponding Graph/Chart) II-22
Battling Alzheimer's Disease - A Powerful Market Force for
Nuclear Medicine II-22
Hypoxia Imaging - The Future of Cancer Therapy II-23
PET or SPECT for Cardiac Imaging - The Debate Continues II-23
Table 20: Worldwide Installed Base of Nuclear Imaging Devices
by Modality (2013) Percentage Share Breakdown of Number of
Installations for SPECT and PET (includes corresponding
Graph/Chart) II-24
Global Nuclear Medicine Market - A Historic Perspective Builder II-24
Table 21: Global Gamma Cameras (SPECT) Market (2006):
Installed Base in Units by Select Country - USA, Japan,
Canada, and UK (includes corresponding Graph/Chart) II-24

Table 22: Global PET Scanners Market (2006): Installed Base
in Units by Select Country - USA, Europe, Japan, Germany,
Canada, UK, France, Italy, and Belgium (includes
corresponding Graph/Chart) II-25
Innovative Radiotracers - Key to PET & SPECT Success II-25
Innovative Biomarkers to Extend PET in Oncology II-26
Application of PET in Drug Development to Expand Opportunities II-26
SPECT Innovations to Improve Efficiency II-27
Cardiocentric SPECT II-27
Cardio-Focused Collimation II-28
Mobile Devices - Future of Diagnostic Imaging? II-28
Growing Smartphone Sales - A Business Case II-28
Table 23: World Market for Smartphones (2011, 2013 & 2017P):
Breakdown of Sales in Thousand Units by Geographic
Region/Country (includes corresponding Graph/Chart) II-29
Global Technetium Shortage Eased II-29
Ageing Population - A Vital Demography II-30
Table 24: Global Population Statistics for the 65+ Age Group
(Male & Female) for Major Countries/Regions: 2013E (includes
corresponding Graph/Chart) II-31

Table 25: Percentage of Population Aged 65 and Above in
Europe, US, and Japan (1960-2030) (includes corresponding
Graph/Chart) II-32

Table 26: Elderly Population (65+ Years) as a Percentage of
the Total Population: 2025 (includes corresponding
Graph/Chart) II-32
PET Eats its Way into Conventional Gamma Camera Market II-32
Factors Restricting Market Growth II-33
High Costs - A Major Threat for Market Growth II-33
Supply Shortages: A Niggling Cause of Concern II-33
Canadian Scientists Discover Means to Address Supply Shortages II-34
Price Sensitivity & Competition from Alternatives Limit
Market Potential II-34
Unfounded Fears of Radiation Exposure Hinder Growth II-35
Bottlenecks in Developing Markets II-35

3. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW II-36
Medical Imaging - Changing the Landscape of Clinical Diagnosis II-36
Image-Guided Interventions - Driving Growth in Nuclear
Medicine Arena II-36
Understanding the Concept II-36
Tremendous Market Potential II-36
Clinical Application Areas II-36
Diagnostic Imaging Witnesses Dramatic Growth II-37
Table 27: Global Medical Imaging Equipment Installed Base
(2013): Percentage Share Breakdown of Volume Installations
for X-ray, Ultrasound, Magnetic Resonance, Computed
Tomography, and Nuclear Medicine/PET by Country/Region
(includes corresponding Graph/Chart) II-38
Comparison of Modalities by Various Imaging Systems II-38
Medical Imaging Equipment Manufacturers Fine Tune Technologies II-39
Future Growth Prospects for Medical Imaging Equipment Market II-39
Multiple Factors Support Global MRI Equipment Market Growth II-39
Reimbursement Remains the Core Issue II-40

4. CANCER - A GLOBAL CONCERN II-41
Cancer Incidence - Statistics on New Cases II-41
Cancer Incidence in Developing Countries II-41
Cancer in Asia II-42
Cancer Cases - Mortality Rates II-42

5. NUCLEAR MEDICINE - AN INSIGHT II-43
Distinct from General Radiology II-43
History II-43
Major Developments II-44
Nuclear Medicine Scans II-44
Bone Scan II-45
Brain Scan II-45
Gallbladder Scan II-45
Kidney Scan II-46
Liver Scan II-46
Lung Scan II-46
Thyroid Scan II-46
Scrotal Scan II-47
Applications II-47
Cardiac Applications II-47
Neurologic Applications II-47
Oncologic Applications II-47
Orthopedic Applications II-48
Pulmonary Applications II-48
Renal Applications II-48
Other Applications II-48
Table 28: Estimated Time Allocations for Nuclear Medicine
Procedures II-49
Radioisotopes: Essential for Nuclear Medicine Procedure II-49
Radioisotopes Used in Medicine II-50
Clinical Applications of Select Isotopes II-51
Radionuclides in Nuclear Medicine Procedures II-52
Table 29: Positron-Emitting Radionuclides in PET Procedures II-53

6. NUCLEAR MEDICINE IMAGING EQUIPMENT II-54
Single-Photon Emission Computed Tomography (SPECT) Systems II-54
SPECT/CT Systems II-54
Positron Emission Tomography (PET) Scanners II-55
Factors Influencing Growth of PET Scanners II-55
PET/CT Systems II-55
PET & Other Imaging Modalities II-56
PET provides the following advantages over other imaging
procedures: II-56
Table 30: Comparison of PET and Conventional Imaging
Techniques (includes corresponding Graph/Chart) II-57
Brain Imaging II-57
Alzheimer's Disease II-58
Brain Trauma II-58
Epilepsy II-58
Heart Imaging II-58
Parkinson's Disease II-58
Cancer II-58
PET-CT: An Advancement in Cancer Diagnosis & Treatment II-59
Mobile PET II-59

7. RESEARCH AND DEVELOPMENT IN THE RECENT PAST II-60
Researchers Develop Portable PET Scanner, SynchroPET II-60
Philips and University Medical Center Hamburg-Eppendorf
Develop MRI/PET Imaging Tool II-60
Indian Scientists Develop Low-Cost Nuclear Medicine Kit II-60

8. PRODUCT INNOVATIONS/INTRODUCTIONS II-61
Philips Introduces Vereos Digital PET/CT II-61
Siemens Unveils Biograph mCT Flow II-61
MR Solutions to Unveil Revolutionary 3T, MR/PET Combined Scanner II-61
DDD Obtains FDA Approval for CorCam™ II-61
Digirad Introduces Imaging Accessory for Molecular Breast Imaging II-61
GE Unveils Discovery PET/CT 610 and Q. Suite II-61
Agfa Healthcare to Introduce Upgraded Version of IMPAX II-62
GE Secures FDA Clearance for Brivio NM615 II-62

9. RECENT INDUSTRY ACTIVITY II-63
AAA Takes Over UK-based Nuclear Medicine Company II-63
BC Technical Inc Acquires NC Systems II-63
BC Technical Acquires Xpert II-63
GE Healthcare Acquires Orbotech Medical Solutions II-63
Comecer Acquires Veenstra Instruments II-63
GE Healthcare Collaborates with NXT2B II-63
Zecotek Inks Development Deal with NuCare II-64
Siemens Healthcare receives FDA Clearance for Biograph mCT PET
CT Scanner II-64
GE Healthcare Receives US FDA Clearance for Brivo NM615 Gamma
Camera II-64

10. FOCUS ON SELECT GLOBAL PLAYER II-65
Digirad Corp. (US) II-65
GE Healthcare Plc (UK) II-65
Mediso Medical Imaging Systems (Hungary) II-66
Philips Healthcare (US) II-66
Positron Corporation (US) II-66
Siemens Healthcare (Germany) II-67

11. GLOBAL MARKET PERSPECTIVE II-68
Table 31: World Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) II-68

Table 32: World Historic Review for Nuclear Medicine Imaging
Equipment by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-69

Table 33: World 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Geographic Region - Percentage Breakdown
of Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2006, 2014, & 2020 (includes corresponding Graph/Chart) II-70
Nuclear Medicine Imaging Equipment Market by Product Segment II-71
Table 34: World Recent Past, Current & Future Analysis for
SPECT Systems by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-71

Table 35: World Historic Review for SPECT Systems by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-72

Table 36: World 15-Year Perspective for SPECT Systems by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2006, 2014, &
2020 (includes corresponding Graph/Chart) II-73

Table 37: World Recent Past, Current & Future Analysis for PET
Scanners by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-74

Table 38: World Historic Review for PET Scanners by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-75

Table 39: World 15-Year Perspective for PET Scanners by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2006, 2014, &
2020 (includes corresponding Graph/Chart) II-76


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Market Snapshots III-1
Nuclear Medicine Market Drivers and Constraints III-2
Nuclear Medicine Market in the US Rebounds in 2011 III-2
Demographic Changes Offer Growth Opportunities III-2
Table 40: North American Aging Population by Age Group:
1975-2050 (includes corresponding Graph/Chart) III-3
Therapeutic Applications to Drive Growth in the US Nuclear
Medicine Market III-3
Market Witnesses Entry of High Value Products III-4
Adoption of SPECT/CT Increasing in the US III-4
PET Procedures in the US Increase III-4
Nuclear Cardiology: Primary Growth Propellant III-5
Dedicated Cardiac PET - The Future of Cardiac Imaging III-5
Personalized Medicine - A Major Driver III-5
Rising Incidence of Cancer - A Major Growth Driver III-6
Table 41: US Cancer Fatalities by Gender (2014): Percentage
Share Breakdown of No. of Deaths for Men and Women
(includes corresponding Graph/Chart) III-6

Table 42: New Cancer Cases by Gender and Affected Site in
the US (2013) III-7
Managing Alzheimer's Opens New Avenues for PET/SPECT III-8
Alzheimer's Stats III-8
Table 43: Alzheimer's Prevalence in the US: As a
Percentage of Population by Age-Group (includes
corresponding Graph/Chart) III-8

Table 44: Alzheimer's Prevalence in the US by State: 2014 &
2025 (includes corresponding Graph/Chart) III-9
Expanding Applications of Radiopharmaceuticals to Stimulate
Growth III-10
Table 45: Usage of Radiopharmaceutical Agents by Nuclear
Medicine Imaging Procedure in the US (2012): Percentage
Share Breakdown of Procedure Volume by Type - SPECT and PET
(includes corresponding Graph/Chart) III-10

Table 46: US Market for Radiopharmaceuticals Agents by
Application (2012): Percentage Share Breakdown of Value
Sales for Cardiology and Non-Cardiology Applications
(includes corresponding Graph/Chart) III-10
Isotope Shortage Leads to Dependence on Imports III-10
DOE's Flawed Isotope Program Adds to the Woe III-11
US Fluorodeoxyglucose (FDG) Market III-11
Table 47: US FDG Market by Procedure Type (2012):
Percentage Share Breakdown of Procedure Volume for
Oncology, Neurology, and Cardiology (includes corresponding
Graph/Chart) III-11
Nuclear Medicine Provision Industry Gradually Moves towards
Consolidation III-12
Medical Imaging and Nuclear Medicine III-12
Table 48: US Medical Imaging Market by Modality (2013):
Percentage Share Breakdown of Revenues for Computed
Tomography Imaging, Contrast Agent and Injector, MRI,
Nuclear Medicine, Ultrasound Imaging and X-Ray Imaging
(includes corresponding Graph/Chart) III-12
Competition III-13
Gamma Cameras III-13
Table 49: US Gamma Camera Market by Leading Players
(2013): Percentage Share Breakdown of Value Sales for
Digirad Corporation, GE Healthcare, Philips Healthcare,
Siemens Healthcare and Others (includes corresponding
Graph/Chart) III-13

Table 50: The US Gamma Camera Market in Cardiology
Application by Leading Player (2013): Percentage Share
Breakdown of Value Sales for Digirad Corporation, GE
Healthcare, Philips Healthcare and Siemens Healthcare
(includes corresponding Graph/Chart) III-13
PET Scanners III-13
Table 51: US PET Market by Leading Players (2013):
Percentage Market Share Breakdown of Value Sales for GE
Healthcare, Philips Healthcare, Siemens Healthcare and
Others (includes corresponding Graph/Chart) III-14
Regulatory Overview III-14
Nuclear Regulatory Commission (NRC) III-14
Food and Drug Administration (FDA) III-14
Environmental Protection Agency (EPA) III-14
Centers for Medicare & Medicaid Services (CMS) III-15
Overview of Medicare Reimbursements III-15
Medicare Payment Settings for Contrast Agents and
Radiopharmaceuticals III-15
Medicare Coverage III-15
Product Launches III-16
Strategic Corporate Development III-16
Select Key Players III-17
B.Market Analytics III-19
Table 52: The US Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems (with Single Head Gamma Cameras, Dual Head
Gamma Cameras, and Triple Head Gamma Cameras) and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-19

Table 53: The US Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems (with
Single Head Gamma Cameras, Dual Head Gamma Cameras, and
Triple Head Gamma Cameras) and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-20

Table 54: The US 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems (with Single Head Gamma
Cameras, Dual Head Gamma Cameras, and Triple Head Gamma
Cameras) and PET Scanners Markets for Years 2006, 2014, &
2020 (includes corresponding Graph/Chart) III-21

2. CANADA III-22
A.Market Analysis III-22
Current & Future Analysis III-22
Canada Faces Paucity of PET Scanners III-22
PET Imaging for Cancer - A Long Way to Go III-22
Canadian Scientists Discover Remedy for Isotope Shortages III-23
An Overview of Medical Imaging Market III-23
Regulatory and Legal Restrictions III-24
Product Launch III-24
B.Market Analytics III-25
Table 55: Canadian Recent Past, Current & Future Analysis
for Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-25

Table 56: Canadian Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-26

Table 57: Canadian 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-27

3. JAPAN III-28
A.Market Analysis III-28
Japanese Healthcare System: An Overview III-28
Fast Facts III-28
Demographics Drive Market Growth III-28
Table 58: Japanese Population by Age Group (2012) (includes
corresponding Graph/Chart) III-28

Table 59: Japanese 65+ Years Population: 1950-2010
(includes corresponding Graph/Chart) III-29
Market Scenario III-29
Table 60: PET Studies Performed in Japan (2008): Percentage
Breakdown by Type - Tumor, Brain, Heart, and Others
(includes corresponding Graph/Chart) III-29
Production and Exports of Nuclear medicine imaging equipment
Suffer in Japan III-30
Reimbursement Issues III-30
Government Initiatives III-30
B.Market Analytics III-31
Table 61: Japanese Recent Past, Current & Future Analysis
for Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-31

Table 62: Japanese Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-32

Table 63: Japanese 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-33

4. EUROPE III-34
A.Market Analysis III-34
Debt Crisis in Europe Affects Healthcare Industry III-34
European Healthcare System: In a State of Transition? III-34
Table 64: European Installed Base for Diagnostic Imaging
Equipment by Modality (2013): Percentage Share Breakdown of
Volume Installations for SPECT, PET/CT, SPECT/CT, Planar,
Cardiac SPECT, and PET/MR (includes corresponding
Graph/Chart) III-35
Oncology Dominates Nuclear Medicine Procedure III-35
Table 65: Cancer Incidence in Europe by Site: 2012 (in
Thousands) (includes corresponding Graph/Chart) III-36

Table 66: European Nuclear Medicine Market by Therapeutic
Area: Percentage Share Breakdown of Imaging Volume for
Oncology, Cardiac, Endocrine, Lung, Renal, Brain and
Infection (includes corresponding Graph/Chart) III-37
Ageing Demography - An Opportunity Indicator III-37
Table 67: Population Breakup by Age Group for Select
European Countries: 2011 (as a Percentage of Total
Population) (includes corresponding Graph/Chart) III-38
B.Market Analytics III-39
Table 68: European Recent Past, Current & Future Analysis
for Nuclear Medicine Imaging Equipment by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-39

Table 69: European Historic Review for Nuclear Medicine
Imaging Equipment by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-40

Table 70: European 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets for Years 2006,
2014, & 2020 (includes corresponding Graph/Chart) III-41

Table 71: European Recent Past, Current & Future Analysis
for Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-42

Table 72: European Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-43

Table 73: European 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-44

4a. FRANCE III-45
Market Analysis III-45
Table 74: French Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-45

Table 75: French Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-46

Table 76: French 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-47

4b. GERMANY III-48
Market Analysis III-48
Table 77: German Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-48

Table 78: German Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-49

Table 79: German 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-50

4c. ITALY III-51
A.Market Analysis III-51
Current & Future Analysis III-51
Product Launch III-51
B.Market Analytics III-52
Table 80: Italian Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-52

Table 81: Italian Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-53

Table 82: Italian 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-54

4d. THE UNITED KINGDOM III-55
A.Market Analysis III-55
Current & Future Analysis III-55
Strategic Corporate Development III-55
Ge Healthcare Plc - A Key Player in The Uk III-55
B.Market Analytics III-56
Table 83: The UK Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-56

Table 84: The UK Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-57

Table 85: The UK 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-58

4e. SPAIN III-59
Market Analysis III-59
Table 86: Spanish Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-59

Table 87: Spanish Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-60

Table 88: Spanish 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-61

4f. RUSSIA III-62
A.Market Analysis III-62
Current & Future Analysis III-62
B.Market Analytics III-62
Table 89: Russian Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-62

Table 90: Russian Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-63

Table 91: Russian 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-64

4g. REST OF EUROPE III-65
A.Market Analysis III-65
Current & Future Analysis III-65
Mediso Medical Imaging Systems (Hungary) - A Key Player III-65
Strategic Corporate Development III-65
B.Market Analytics III-66
Table 92: Rest of European Recent Past, Current & Future
Analysis for Nuclear Medicine Imaging Equipment by Product
Segment - SPECT Systems and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-66

Table 93: Rest of Europe Historic Review for Nuclear
Medicine Imaging Equipment by Product Segment - SPECT
Systems and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-67

Table 94: Rest of Europe 15-Year Perspective for Nuclear
Medicine Imaging Equipment by Product Segment - Percentage
Breakdown of Value Sales for SPECT Systems and PET Scanners
Markets for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-68

5. ASIA-PACIFIC III-69
A.Market Analysis III-69
Current & Future Analysis III-69
Burden of Chronic Diseases in Aging Populace - Potential
Opportunities for Nuclear Medicine III-69
Table 95: Over 65 Years Individuals as % of Total
Population in Select Asian Countries (includes
corresponding Graph/Chart) III-70
India & China Offer Significant Growth Opportunities III-71
Table 96: China and India Leads Global Population (July
2013): Table Depicting China and India's Huge Population
Vis-a-vis Other Countries' Population (in Million) by Age
Group (includes corresponding Graph/Chart) III-71

Table 97: Age-wise Breakup of China and India's Population
Vis-à-vis Other Populous Countries Globally: As of July
2013 (includes corresponding Graph/Chart) III-72
B.Market Analytics III-73
Table 98: Asia-Pacific Recent Past, Current & Future
Analysis for Nuclear Medicine Imaging Equipment by
Geographic Region - China, India and Rest of Asia-Pacific
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-73

Table 99: Asia-Pacific Historic Review for Nuclear Medicine
Imaging Equipment by Geographic Region - China, India and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-74

Table 100: Asia-Pacific 15-Year Perspective for Nuclear
Medicine Imaging Equipment by Geographic Region - Percentage
Breakdown of Value Sales for China, India and Rest of
Asia-Pacific Markets for Years 2006, 2014, & 2020 (includes
corresponding Graph/Chart) III-75

Table 101: Asia-Pacific Recent Past, Current & Future
Analysis for Nuclear Medicine Imaging Equipment by Product
Segment - SPECT Systems and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-76

Table 102: Asia-Pacific Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-77

Table 103: Asia-Pacific 15-Year Perspective for Nuclear
Medicine Imaging Equipment by Product Segment - Percentage
Breakdown of Value Sales for SPECT Systems and PET Scanners
Markets for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-78

5a. CHINA III-79
A.Market Analysis III-79
Current & Future Analysis III-79
Medical Imaging Device Market - An Overview III-79
Increasing Expenditure on Healthcare Sector III-79
B.Market Analytics III-80
Table 104: Chinese Recent Past, Current & Future Analysis
for Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-80

Table 105: Chinese Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-81

Table 106: Chinese 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-82

5b. INDIA III-83
A.Market Analysis III-83
Current & Future Analysis III-83
Table 107: Installed Base of Nuclear Medicine Scanners in
India in 2011 (includes corresponding Graph/Chart) III-83
India Offers High Growth Potential III-83
Regulatory Mechanism for Guiding Isotope Production and
Distribution III-84
PET/CT Scanning in India Gathers Momentum III-84
Overview of CT Scanners Market in India III-84
Developments in Clinical Practice and Technology III-85
Product Launch III-85
B.Market Analytics III-86
Table 108: Indian Recent Past, Current & Future Analysis for
Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-86

Table 109: Indian Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-87

Table 110: Indian 15-Year Perspective for Nuclear Medicine
Imaging Equipment by Product Segment - Percentage Breakdown
of Value Sales for SPECT Systems and PET Scanners Markets
for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-88

5c. REST OF ASIA-PACIFIC III-89
A.Market Analysis III-89
Current & Future Analysis III-89
Korea III-89
Strategic Corporate Development III-89
B.Market Analytics III-90
Table 111: Rest of Asia-Pacific Recent Past, Current &
Future Analysis for Nuclear Medicine Imaging Equipment by
Product Segment - SPECT Systems and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-90

Table 112: Rest of Asia-Pacific Historic Review for Nuclear
Medicine Imaging Equipment by Product Segment - SPECT
Systems and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-91

Table 113: Rest of Asia-Pacific 15-Year Perspective for
Nuclear Medicine Imaging Equipment by Product Segment -
Percentage Breakdown of Value Sales for SPECT Systems and
PET Scanners Markets for Years 2006, 2014, & 2020 (includes
corresponding Graph/Chart) III-92

6. LATIN AMERICA III-93
A.Market Analysis III-93
Current & Future Analysis III-93
B.Market Analytics III-94
Table 114: Latin American Recent Past, Current & Future
Analysis for Nuclear Medicine Imaging Equipment by
Geographic Region - Brazil and Rest of Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-94

Table 115: Latin American Historic Review for Nuclear
Medicine Imaging Equipment by Geographic Region - Brazil and
Rest of Latin America Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-95

Table 116: Latin American 15-Year Perspective for Nuclear
Medicine Imaging Equipment by Geographic Region - Percentage
Breakdown of Value Sales for Brazil and Rest of Latin
America Markets for Years 2006, 2014, & 2020 (includes
corresponding Graph/Chart) III-96

Table 117: Latin American Recent Past, Current & Future
Analysis for Nuclear Medicine Imaging Equipment by Product
Segment - SPECT Systems and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-97

Table 118: Latin American Historic Review for Nuclear
Medicine Imaging Equipment by Product Segment - SPECT
Systems and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-98

Table 119: Latin American 15-Year Perspective for Nuclear
Medicine Imaging Equipment by Product Segment - Percentage
Breakdown of Value Sales for SPECT Systems and PET Scanners
Markets for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-99

6a. BRAZIL III-100
A.Market Analysis III-100
Current & Future Analysis III-100
B.Market Analytics III-100
Table 120: Brazilian Recent Past, Current & Future Analysis
for Nuclear Medicine Imaging Equipment by Product Segment -
SPECT Systems and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-100

Table 121: Brazilian Historic Review for Nuclear Medicine
Imaging Equipment by Product Segment - SPECT Systems and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-101

Table 122: Brazilian 15-Year Perspective for Nuclear
Medicine Imaging Equipment by Product Segment - Percentage
Breakdown of Value Sales for SPECT Systems and PET Scanners
Markets for Years 2006, 2014, & 2020 (includes corresponding
Graph/Chart) III-102

6b. REST OF LATIN AMERICA III-103
A.Market Analysis III-103
Current & Future Analysis III-103
B.Market Analytics III-103
Table 123: Rest of Latin America Recent Past, Current &
Future Analysis for Nuclear Medicine Imaging Equipment by
Product Segment - SPECT Systems and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-103

Table 124: Rest of Latin America Historic Review for Nuclear
Medicine Imaging Equipment by Product Segment - SPECT
Systems and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-104

Table 125: Rest of Latin America 15-Year Perspective for
Nuclear Medicine Imaging Equipment by Product Segment -
Percentage Breakdown of Value Sales for SPECT Systems and
PET Scanners Markets for Years 2006, 2014, & 2020 (includes
corresponding Graph/Chart) III-105

7. REST OF WORLD III-106
A.Market Analysis III-106
Current & Future Analysis III-106
Strategic Corporate Development III-106
B.Market Analytics III-107
Table 126: Rest of World Recent Past, Current & Future
Analysis for Nuclear Medicine Imaging Equipment by Product
Segment - SPECT Systems and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-107

Table 127: Rest of World Historic Review for Nuclear
Medicine Imaging Equipment by Product Segment - SPECT
Systems and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2006 through
2012 (includes corresponding Graph/Chart) III-10
Read the full report: http://www.reportlinker.com/p02365016-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com